SEC Info - Ani Pharmaceuticals Inc. - ‘S-8’ on 11/23/20

SEC Info℠

Home

Help

Please Sign In

Ani Pharmaceuticals Inc. – ‘S-8’ on 11/23/20 – ‘EX-23.1’

On: Monday, 11/23/20, at 4:27pm ET · Effective: 11/23/20 · Accession #: 1104659-20-128469 · File #: 333-250892

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/23/20  Ani Pharmaceuticals Inc.          S-8        11/23/20    3:92K                                    Toppan Merrill/FA

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     44K 
                Employee Benefit Plan                                            
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     10K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML      5K

‘EX-23.1’ — Consent of Expert or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in this Registration Statement of ANI Pharmaceuticals, Inc. on Form S-8 to be filed on or about November 23, 2020 of our reports dated February 27, 2020, on our audits of the consolidated financial statements as of December 31, 2019 and 2018, and for each of the years in the three-year period ended December 31, 2019, and the effectiveness of ANI Pharmaceuticals, Inc.’s internal control over financial reporting as of December 31, 2019, which reports were included in the Annual Report on Form 10-K filed February 27, 2020.

/s/ EisnerAmper LLP

EISNERAMPER LLP

Philadelphia, Pennsylvania

November 23, 2020

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed on / Effective on:	11/23/20
	2/27/20	10-K, 8-K
	12/31/19	10-K
	12/31/18	10-K, 5
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/23/23  Ani Pharmaceuticals Inc.          S-8         6/23/23    5:110K                                   Toppan Merrill/FA

4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/05/20  Ani Pharmaceuticals Inc.          10-Q        9/30/20   78:9M
 4/23/20  Ani Pharmaceuticals Inc.          DEF 14A     6/05/20    1:8.3M                                   Toppan Merrill/FA
 2/27/20  Ani Pharmaceuticals Inc.          10-K       12/31/19   96:12M                                    Toppan Merrill/FA
 7/19/13  Ani Pharmaceuticals Inc.          8-A12B/A               1:20K                                    Toppan Merrill/FA

↑Top

Filing Submission 0001104659-20-128469 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)